Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2000
12/07/2000WO2000072825A1 Novel formulations comprising lipid-regulating agents
12/07/2000WO2000072823A1 Preparations for the application of anti-inflammatory agents
12/07/2000WO2000072822A1 Preparations for the application of anti-infective and/or anti-inflammatory agents
12/07/2000WO2000072820A2 Injectable anesthetic formulation
12/07/2000WO2000072818A1 Topical compositions providing improved treatment of skin or scalp fungal infections
12/07/2000WO2000072815A1 Indole derivatives
12/07/2000WO2000072813A1 Method of treating hair loss using diphenylmethane derivatives
12/07/2000WO2000072812A1 Method of treating hair loss using diphenylether derivatives
12/07/2000WO2000072811A1 Method of treating hair loss
12/07/2000WO2000072810A1 Method of treating hair loss using sulfonyl thyromimetic compounds
12/07/2000WO2000072806A2 Sunscreen composition containing sol-gel microcapsules
12/07/2000WO2000072801A2 Alpha v integrin receptor antagonists
12/07/2000WO2000072799A2 Method and compositions for treating the inflammatory response
12/07/2000WO2000072698A1 Process and product for enhancing immune response in companion animal using a combination of antioxidants
12/07/2000WO2000072679A1 Osteonectin based toxic gene therapy for the treatment of calcified tumors and tissues
12/07/2000WO2000051615B1 Synergistic combinations of guanosine analog reverse transcriptase inhibitors and inosine monophosphate dehydrogenese inhibitors and uses therefor
12/07/2000WO2000050035A3 Premixed formulation of piperacillin sodium and tazobactam sodium injection
12/07/2000WO2000050018A3 Pharmaceutical preparation containing dithranol
12/07/2000WO2000049937A3 Trpm-2 antisense therapy
12/07/2000WO2000048584A3 Aroyl aminoacyl pyrroles for use in the treatment of neuropathic pain
12/07/2000WO2000048583A3 Formulation of 5-ht agonists with nsaids, especially cox-2 inhibitors, for treating migraine
12/07/2000WO2000048559A3 Composition for promoting hair growth comprising derivatives of vitamins and dmso
12/07/2000WO2000046391A3 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
12/07/2000WO2000046224A3 Tricyclic pyridine n-oxides vasopressin agonists
12/07/2000WO2000045849A3 Use of cationic lipids to generate anti-tumor immunity
12/07/2000WO2000045801A3 Use of a nitrate vasodilator alone or in combination with capsaicin for the treatment of pain
12/07/2000WO2000044741A3 Process to prepare cyclic-sulfur fluorine containing oxazolidinones
12/07/2000WO2000044392A3 Identification of specific differentially expressed mycobacterial antigens
12/07/2000WO2000042996A3 Use of anticonvulsant derivatives for treating cluster headaches
12/07/2000WO2000041681A3 MEDICINAL FORMULATIONS CONTAINING AN OPIOID AND AN α-ANTAGONIST
12/07/2000WO2000041514A3 Conjugates of colony stimulating factors for targeting and imaging infection and inflammation
12/07/2000WO2000038668A3 Use of a nitrosourea derivative for prevention or treatment of acute allograft rejection
12/07/2000WO2000037141A9 Combination chemotherapy
12/07/2000WO2000035443A9 Method and composition for the maintenance and restitution of gut integrity
12/07/2000WO2000032176A3 Use of 17-ketosteroids for the treatment of toxoplasmosis and cryptosporidosis
12/07/2000WO2000031247A3 Recombinant methods and materials for producing epothilone and epothilone derivatives
12/07/2000WO2000024390A9 Method and composition for modulating amyloidosis
12/07/2000WO2000009104A3 Use of sulfonamides for treating vision and memory disorders
12/07/2000WO1999060988A3 Combination therapy for treatment of fiv infection
12/07/2000DE19925613A1 Verbundlaminat und Verfahren zu seiner Herstellung A composite laminate and method of production
12/07/2000DE19925211A1 Kit for preparing stable paclitaxel formulation for use as anticancer agent, comprising separately stored drug, solution of anhydrous citric acid in ethanol and solution of polyethoxylated castor oil in ethanol
12/07/2000DE19925143A1 Neue liposomale Vektorkomplexe und deren Verwendung für die Gentherapie New liposomal vector complexes and their use for gene therapy
12/07/2000DE19924892A1 Neue Carbonsäurederivate mit arylsubstituierten Stickstoffheterocyclen, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten New carboxylic acid derivatives with aryl-substituted nitrogen heterocycles, their preparation and use as endothelin receptor antagonists
12/07/2000DE19924148A1 Sphingomyelinasehemmer Sphingomyelinasehemmer
12/07/2000DE19919585A1 Verwendung von Phyllanthus zur Behandlung von oxidativem Streß und anderen Symptomen Use of Phyllanthus for the treatment of oxidative stress and other symptoms
12/07/2000CA2694866A1 Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts
12/07/2000CA2383244A1 Protein kinases
12/07/2000CA2376024A1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
12/07/2000CA2375850A1 Method and compositions relating to insulin resistance disorders
12/07/2000CA2375826A1 Novel epidermal growth factor receptor-binding compounds for positron emission tomography
12/07/2000CA2375822A1 Substituted biaryl ether compounds
12/07/2000CA2375683A1 Il-8 receptor antagonists
12/07/2000CA2375674A1 Biaryl compounds
12/07/2000CA2375667A1 Sulfur-containing thyroxane derivatives and their use as hair growth promotors
12/07/2000CA2375666A1 Novel carboxylic acid derivatives comprising aryl-substituted nitrogen heterocycles, their production and their use as endothelin receptor antagonists
12/07/2000CA2375633A1 Cranberry seed oil extract and compositions containing components thereof
12/07/2000CA2375630A1 Antibacterial compounds
12/07/2000CA2375348A1 Novel antioxidants, preparation methods and uses
12/07/2000CA2375253A1 Semi-synthesis of paclitaxel using dialkyldichlorosilanes
12/07/2000CA2375237A1 Method of sterilizing
12/07/2000CA2375218A1 Squaric acid derivatives as cell adhesion molecules
12/07/2000CA2375196A1 Use of gabapentin in assays to identify gabab receptor modulators
12/07/2000CA2375188A1 Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors
12/07/2000CA2375186A1 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect
12/07/2000CA2375147A1 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
12/07/2000CA2375095A1 Groel muteins with improved stability
12/07/2000CA2375047A1 Dna encoding snorf33 receptor
12/07/2000CA2374921A1 Neuronal death inhibitors
12/07/2000CA2374387A1 Adipocyte complement related protein homolog zacrp7
12/07/2000CA2374310A1 Nutritional supplements
12/07/2000CA2374295A1 Il-8 receptor antagonists
12/07/2000CA2374288A1 Novel formulations comprising lipid-regulating agents
12/07/2000CA2374266A1 Method of treating hair loss using diphenylmethane derivatives
12/07/2000CA2374263A1 Method of treating hair loss using diphenylether derivatives
12/07/2000CA2374262A1 Method of treating hair loss
12/07/2000CA2374260A1 Method of treating hair loss using sulfonyl thyromimetic compounds
12/07/2000CA2374175A1 Compounds and methods for the treatment of post traumatic stress disorder
12/07/2000CA2374141A1 Osteonectin based toxic gene therapy for the treatment of calcified tumors and tissues
12/07/2000CA2374129A1 Therapeutic use of melatonin
12/07/2000CA2374117A1 Novel formulations comprising lipid-regulating agents
12/07/2000CA2373937A1 Alpha v integrin receptor antagonists
12/07/2000CA2373726A1 Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvic area
12/07/2000CA2373638A1 Adam polynucleotides and polypeptides
12/07/2000CA2373210A1 Fused polycyclic amino acids as pharmaceutical agents
12/07/2000CA2372250A1 Fimbrial proteins
12/07/2000CA2372236A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo¬2,2,2|oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate as nk-1 receptor antagonists
12/07/2000CA2372233A1 Bicyclic oxazolidinones as antibacterial agent
12/07/2000CA2371995A1 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
12/07/2000CA2371395A1 Amino heterocycles useful as pharmaceutical agents
12/07/2000CA2371092A1 Cell proliferation inhibitors
12/07/2000CA2371089A1 3-heteroarylalkyl substituted gaba analogs
12/07/2000CA2371033A1 Injectable anesthetic formulation
12/07/2000CA2370598A1 Substituted 8-phenylxanthines useful as antagonists of a2b adenosine receptors
12/07/2000CA2370364A1 Sunscreen composition containing sol-gel microcapsules
12/07/2000CA2368192A1 Preparations for the application of antiseptic agents to the interior of the human or animal body
12/07/2000CA2339131A1 Nucleic acid molecules with specific recognition of native prpsc, production and use
12/06/2000EP1057872A1 Elastomeric silicone containing an active ingredient
12/06/2000EP1057832A1 Substance having steroid-like structure, process for the production thereof and antitumor agents containing the same
12/06/2000EP1057828A2 Trovafloxacin oral suspensions
12/06/2000EP1057826A1 Substituted dimeric carboxamide derivatives, method for preparing them, and pharmaceutical compositions containing them
1 ... 6196 6197 6198 6199 6200 6201 6202 6203 6204 6205 6206 6207 6208 6209 6210 6211 6212 6213 6214 6215 6216 ... 7860